4//SEC Filing
Leonard Frank X 4
Accession 0001562180-24-001988
CIK 0001645113other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:38 PM ET
Size
14.4 KB
Accession
0001562180-24-001988
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leonard Frank X
EVP, Pres., Novocure Oncology
Transactions
- Sale
Ordinary Shares
2024-02-28$16.14/sh−2,078$33,545→ 162,617 total - Award
Ordinary Shares
2024-02-27$16.30/sh+102,249$1,666,659→ 164,695 total - Award
Stock Options (Right to buy)
2024-02-27$16.30/sh+156,348$2,548,472→ 156,348 totalExercise: $16.30From: 2025-02-27Exp: 2034-02-26→ Ordinary Shares (156,348 underlying)
Footnotes (3)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Options to buy 156,348 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001822879
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:38 PM ET
- Size
- 14.4 KB